In a recent discussion, Professor Woroń highlighted the dangers of what he termed 'painful supplementation,' where specific supplements, such as ashwagandha, can lead to unfavorable changes in patients, particularly those battling cancer. He noted that these supplements could exacerbate symptoms like peripheral neuropathy, which is critical for patients who are already undergoing treatment for serious illnesses. The phenomenon represents a serious health concern, especially when patients rely on supplements without proper medical guidance.

Moreover, Professor Woroń pointed out that the dietary supplement market in Poland is substantial, valued at approximately 8 billion PLN. A shocking 70-75% of patients are reported to consume these supplements, which raises significant concerns about potential drug-supplement interactions. He emphasized the risk posed by 35% of Polish patients who take more than one supplement, leading to mixtures that could have detrimental effects on their health.

For cancer patients, the consequences could be devastating. Approximately 60% of individuals diagnosed with cancer are using supplements, and many may be putting themselves at risk of adverse effects without realizing it. This situation calls for greater awareness and a more cautious approach to supplement use among patients, particularly those undergoing cancer treatment, to safeguard their health and recovery prospects.